SEATTLE – Oct. 29, 2014 – Fred Hutchinson Cancer Research Center recently was honored as the winner of the Visionary Award in Energy from the 2030 Districts, an interdisciplinary public-private collaborative working to create a groundbreaking building district in downtown Seattle.
Fred Hutch was called out for the performance of its 1100 Eastlake Building, which houses its 10,000-square-foot data center and the staff, faculty and laboratories of its Vaccine and Infectious Disease Division.
The award presentation took place Oct. 9 during the second annual 2030 Districts 2014 Visionary Awards to honor projects that reduce environmental impacts of building construction and operations. “We are honored to receive this award from the 2030 District,” said Scott Rusch, vice president of Facilities and Operations at Fred Hutch. “It really is a testament to the fantastic work done by our teams in Facilities, IT and the design teams who worked on the project.”
The 2030 Districts noted that while labs and data centers are notoriously power-hungry buildings, 1100 Eastlake is “one of the most efficient data centers anywhere” and is “an important example for future projects.”
Measured by Power Usage Effectiveness, an efficiency rating of 1.00 would be perfect and a 1.8 rating would be considered average in the industry. 1100 Eastlake's data center operates at a near-perfect rating of 1.05. The combined energy use intensity (EUI) of the entire building, which includes lab, data center and office space, is 100 kBtu's per square foot per year. With 45 percent lab space, 1100 Eastlake performs at nearly the national median for standard office buildings. Based on information submitted to Labs for the 21st Century, 1100 Eastlake is 39 percent more efficient than the last eight laboratories built in the Northwest and 25 percent more efficient than the next closest lab building.
Fred Hutch built out the data center, office space and labs housed in 1100 Eastlake after purchasing the 177,000-square-foot building in 2010.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.